|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street, SW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Katherine Corwin |
Date | 7/22/2019 10:33:45 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC); Agency for Healthcare Research and Quality (AHRQ); American Indian/Alaska Native Womens Health (IHS); International Family Planning; Health Disparities (HHS); Safe Motherhood (CDC); Global Maternal and Child Health (USAID); Maternal Morbidity and Mortality (CDC, HRSA); Maternal Therapeutics Research and Regulation (HHS, NIH, FDA); Reproductive Health (general); Womens Health Research (NIH); Gun Violence Research (CDC); HIV Prevention (DASH); Medicaid and Medicare (CMS); Division of Reproductive Health (CDC); Pregnancy Risk Assessment Monitoring System (CDC); National Center on Birth Defects and Developmental Disabilities (CDC); National Center for Environmental Health (CDC); Public Health Surveillance (general); National Health Service Corps (HRSA); Substance Use Disorder Treatment (SAMHSA); Office on Smoking and Health (CDC); Title V Block Grant (HRSA); Title X Family Planning Program (OPA); Teen Pregnancy Prevention Program (OAH); Screening and Treatment for Maternal Depression (HHS); Endometriosis (NIH, CDC); Center for Primary Care Research (AHRQ); public health surveillance (CDC); WIC Breastfeeding Peer Counselor Program (Ag); H.R. 2740, Labor, Health and Human Services, Education, Legislative Branch, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; S.___ Labor, Health and Human Services, Education Appropriations Act.
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Office of Management & Budget (OMB), Natl Institutes of Health (NIH), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Food & Drug Administration (FDA), Justice - Dept of (DOJ), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Agency for Healthcare Research & Quality (AHRQ), Indian Health Service, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Sexuality Education (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X Family Planning Program (general); Womens Preventive Services (general); Drug Pricing (general); Administrative Burden (general); Surprise Billing (general); Pediatric Loan Repayment Program (general); H.R. 1551/S.1960, Quality Care for Moms and Babies Act; H.R. 1897/S. 916, MOMMAs Act; H.R. 1763/S. 348, Resident Physician Shortage Reduction Act of 2019; H.R. 1554, Resident Education Deferred Interest Act; H.R.___/S. 116, MOMS Act; S.___, Rural MOMS Act; H.R. 2778/S. 1481, Healthy MOM Act; H.R. 2902/S. 1600, Maternal CARE Act; H.R. 2602/S. 1343, MOMMIES Act; H.R. 1585/S.___, Violence Against Women Reauthorization Act of 2019; S. 130/S. 311, Born-Alive Abortion Survivors Protection Act; H.R. 784/S. 160, Pain-Capable Unborn Child Protection Act; H.R. 2975/S. 1645, Womens Health Protection Act; H.R. 986/S. 466, Protecting Americans with Preexisting Conditions Act; H.R. 1010, To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; H.R. 1143, Educating Consumers on the Risks of Short-Term Plans Act of 2019; S.Res. 29, A resolution expressing support for the designation of a Womens Health Research Day; H.R. 2815/S. 304/S. 1191, Training the Next Generation of Primary Care Doctors Act of 2019; H.R.__/S.__, Wise Investment in our Children Act; H.Res. 317/S.Res. 154, A resolution recognizing Black Maternal Health Week; H.R. 2689/S. 1438, Breast Cancer Research Stamp Reauthorization Act; S. 1895, Lower Health Care Costs Act; H.R. 2862/S. 1619, VACCINES Act; H.R. 3296/S. 1847, Affordability is Access Act; H.R. 2777/S. 1936, Protecting Access to Lifesaving Screenings Act; H.R. 3109, GEDI Act; H.R. 2803/S. 1461, Access to Infertility Treatment and Care Act; H.R. 2411/S. 1258, Tobacco to 21 Act; implementation of P.L. 115-344, Preventing Maternal Deaths Act; implementation of P.L. 115-320, Improving Access to Maternity Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), Indian Health Service, Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Medicare reimbursement (general); Health Care Reform (general); Medicaid DSH Payments (general); H.R. 3107, Improving Seniors Timely Access to Care Act; H.R. 3302, Keep Physicians Serving Patients Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Congressionally Directed Medical Research Programs (CDMRP); Ovarian cancer research (general); Gynecologic cancer (general); Contraception Access (general); Emergency Contraception (general); Military Sexual Trauma (general); Military Womens Health (general); Maternal Mortality and Morbidity (general); Postpartum care (general); Assisted Reproductive Technology (general); H.R. 2091/S. 1049, Access to Contraception for Women Servicemembers and Dependents Act; H.R. 2500/S. 1790/National Defense Authorization Act for Fiscal Year 2020.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Implementation of P.L. 114-182, Frank R. Lautenberg Chemical Safety for the 21st Century Act; H.R. 1243/S. 523, Climate Change Health Protection and Promotion Act;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Womens Health Research (general); Assisted Reproductive Technology (general); Gender based health services (general); Provider scope of practice (general); Military Sexual Trauma (general); Abortion (general); Department of Veterans Affairs Medical and Prosthetic Research program (VA),
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Immigration and womens health (general); Health care work force (general); Abortion (general); Pregnant women in immigration detention; H.R. 3239, Humanitarian Standards for Individuals in Customs and Border Protection Custody Act; H.R. 3563/S. 648, Stop Shackling and Detaining Pregnant Women Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Family planning (general); Maternal health (general). H.R. 1581/S. 707, Reproductive Rights are Human Rights; H.R. 1055/S. 368, Global Health, Empowerment and Rights Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Agency for International Development (USAID), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Tatiana |
Calderon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |